Nuzenio

Allsci Us

Allsci Us entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 24 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 16:51:48 GMTAlmirall taps CrystalO's AI platform to discover ion channel drugs for skin disease - AllSci
Mon, 10 Aug 2026 16:50:24 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSci
Mon, 10 Aug 2026 16:40:47 GMTTenax’s levosimendan fails Phase III LEVEL trial in PH-HFpEF - AllSci
Mon, 10 Aug 2026 16:11:22 GMTBeOne and Revolution Medicines partner on RAS(ON) inhibitor combinations in Asia - AllSci
Mon, 10 Aug 2026 14:39:13 GMTGRAIL’s Galleri becomes first multi-cancer detection test headed to US FDA advisory panel - AllSci
Mon, 10 Aug 2026 14:22:58 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSci

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Allsci Us.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.